| Formulary Chapter 13: Skin - Full Chapter
|
| Notes: |
Please note all items listed in the British Association of Dermatology specials list are classified as having a 'red' traffic light status except for Pigmanorm (non formulary).
Chapter review date: |
|
| Chapter Links... |
 Acne Vulgaris - primary care treatment pathway |
| British Association of Dermatology (BAD) list of recommended special order products |
| Management of psoriasis in adults (September 2019) |
| Pan Dorset Moisture Pathway October 2018 |
| Rosacea Pathway |
| Details... |
| 13.08.01 |
Sunscreen preparations |
|
|
Anthelios XL®
|
Formulary
 
|
Anthelios® XL SPF 50+ Melt-in cream is a borderline substance and regarded as a drug when prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures . Preparations with SPF less than 30 should not normally be prescribed.
 Self Care Medicine for primary care
|
|
|
Dundee reflective sun creams (Dundee Block®)
|
Formulary
|
When prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures.
Self Care Medicine for primary care.
|
Commissioning statement for Dundee sunscreen
|
Sunsense® Ultra
|
Formulary
|
DCHFT: On local formulary.
Sunsense® Ultra is included as a borderline substance and regarded as a drug when prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures. Preparations with SPF less than 30 should not normally be prescribed
Self Care Medicine for primary care..
|
|
|
Uvistat®
|
Formulary
|
Uvistat® Lipscreen SPF 50 and Uvistat® Suncream SPF 30 and 50 are borderline substances and are regarded as drugs when prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures. Preparations with SPF less than 30 should not normally be prescribed
Self Care Medicine for primary care.
|
|
|
|
|
| 13.08.01 |
Photodamage |
|
|
5-aminolevulinic acid hydrochloride (Ameluz®)
|
 Restricted
|
Poole
Treatment of actinic keratosis (AK) of mild to moderate severity on the face and scalp (Olsen grade 1 to 2) and of field cancerization in adults.
Treatment of superficial and/or nodular basal cell carcinoma (BCC) unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.
|
|
|
Actikerall®
|
Formulary
|
Solution, fluorouracil 0.5%, salicylic acid 10%
Not stocked at RBCH
|
|
|
Fluorouracil 5& cream (Efudix®)
|
Formulary
|
Cream, fluorouracil 5%
Excipients include hydroxybenzoates (parabens), polysorbate 60, propylene glycol, stearyl alcohol
|
|
|
Zyclara®
|
Formulary
|
Cream, imiquimod 3.75%
DCHFT and RBCH: Not routinely stocked.
|
|
|
Aldara®
|
Formulary
|
Cream, imiquimod 5%
|
|
|
Methyl-5-Aminolevulinate (Metvix®)
|
Formulary
|
Poole: Treatment of Bowen's Disease - Used in photodyamic therapy
|
|
|
| .... |
| Non Formulary Items |
Borderline Substances (Delph®)
|
Non Formulary
|
|
|
|
Borderline Substances (SpectraBan®)
|
Non Formulary
|
Self Care Medicine for primary care. |
|
|
Ingenol mebutate gel (Picato®)
|
Non Formulary
|
Jan 20 - The European Medicines Agency recommend that patients stop using Picato® (ingenol mebutate), while it continues its review of the medicine's safety.
27/01/20, Leo Laboratories Ltd (T/A LEO Pharma) is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to concerns on the possible risk of skin malignancy |
 Information on the Class II Medicines recall
|
Solaraze®
|
Non Formulary
|
Gel, diclofenac sodium 3% in a sodium hyaluronate basis
Excipients include benzyl alcohol |
|
|
Sunscreen (E45 Sun®)
|
Non Formulary
|
Self Care Medicine for primary care. |
|
|
Sunscreen (Roc®)
|
Non Formulary
|
Self Care Medicine for primary care. |
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
|
|
|
